Journal
PEDIATRICS
Volume 131, Issue 1, Pages 120-127Publisher
AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2012-0852
Keywords
newborn screening; policy; research; ethics; biobank
Categories
Funding
- National Human Genome Research Institute [R01 HG058854]
- National Institutes of Health (NIH)
Ask authors/readers for more resources
The storage and use of residual newborn screening dried blood specimens has generated significant controversy in the past 5 years, primarily because of public concerns over the lack of parental knowledge and consent for these activities. State policies addressing the management of these specimens vary widely, and there is currently little guidance to aid new state policy development to address the concerns of program professionals, investigators, and the general public. This article offers guidance for state policy based on multiple sources of data, including public attitudes, professional statements, state experience, and an analysis of the ethical, social, legal, and biomedical issues from a multidisciplinary group of scholars. This guidance will be useful for state programs that seek to develop policies that are informed by a contemporary analysis of the key ethical, legal, and social aspects of this practice. This article represents the work of the authors and does not represent American Academy of Pediatrics policy. Pediatrics 2013;131:120-127
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available